Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Rheumatology (Oxford, England)|January 19, 2021
Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patientsJeffrey A Sparks, Yinzhu Jin, Soo-Kyung Cho, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 8, 2021
Utilization of targeted disease-modifying anti-rheumatic drugs (DMARDs) for managing rheumatoid arthritis in the last decade: A two-country comparisonSo-Hee Park, Ha-Lim Jeon, Seoyoung C Kim, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 14, 2016
Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort StudyNam-Kyong Choi, Daniel H Solomon, Theodore N Tsacogianis, et al.
Plos One|April 18, 2015
Bisphosphonates and risk of cardiovascular events: a meta-analysisDae Hyun Kim, James R Rogers, Lisa A Fulchino, et al.
Plos One|February 14, 2018
Assessment of coronary vascular function with cardiac PET in relation to serum uric acidSeoyoung C Kim, Nishant R Shah, James R Rogers, et al.
Arthritis Care & Research|May 11, 2021
Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic ArthritisYinzhu Jin, Hemin Lee, Moa P Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 12, 2024
Efficacy Versus Effectiveness: The HORIZON-Pivotal Fracture Trial and Its Emulation in Claims DataElvira D'Andrea, Sebastian Schneeweiss, Jessica M Franklin, et al.
Arthritis Care & Research|August 15, 2017
Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015Moa P Lee, Joyce Lii, Yinzhu Jin, et al.
Arthritis Care & Research|December 17, 2013
Sociodemographic, disease, health system, and contextual factors affecting the initiation of biologic agents in rheumatoid arthritis: a longitudinal studyEdward Yelin, Chris Tonner, Seoyoung C Kim, et al.
Seminars in Arthritis and Rheumatism|April 11, 2019
Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort studySeoyoung C Kim, Ajinkya Pawar, Rishi J Desai, et al.
Pageof 19